Bringing the fundamentals into focus…
Back to Amylyx Pharmaceuticals, Inc.
How Amylyx Pharmaceuticals, Inc. stacks up
AMLX · against 287 other Healthcare companies of similar size
Overall
31/ 100
Near the bottom of its peers.
Ranked #254 of 288 · scores higher than 11% of peers
Bars: peers in each 10-point band of the overall score35 peers with an overall score of 30–39, including AMLX · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around AMLX| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | 100 | 0 / 2 | ||
| 2 | 2.1B USD | 96 | 96 | 99 | 93 | 0 / 2 | |
| 2 | 15.6B DKK (≈$2.3B) | 96 | 96 | 99 | 96 | 0 / 2 | |
| 4 | 37.3B HKD (≈$4.8B) | 90 | 99 | 98 | 84 | 0 / 2 | |
| 5 | 19.7B HKD (≈$2.5B) | 84 | 84 | 98 | 87 | 0 / 2 | |
| 248 | 2.5B USD | 32 | 50 | 34 | 38 | 2 / 2 | |
| 248 | 2.6B USD | 32 | 39 | 36 | 36 | 2 / 2 | |
| 248 | 1.9B USD | 32 | 8 | 94 | 17 | 2 / 2 | |
| 248 | 6.0B USD | 32 | 8 | 91 | 16 | 2 / 2 | |
| 254 | 3.7B USD | 31 | 8 | 8 | 13 | 0 / 2 | |
| 254 | 2.5B USD | 31 | 8 | 64 | 16 | 1 / 2 | |
| 256 | 6.0B USD | 30 | 8 | 82 | 28 | 2 / 2 | |
| 256 | 4.0B USD | 30 | 8 | — | 16 | 0 / 2 | |
| 256 | 5.7B USD | 30 | 8 | 90 | 13 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score